This document discusses a new fertility technique called "three-parent babies" or "early pronuclear transfer" that could help mothers avoid passing on mitochondrial diseases to their children. The technique involves transferring the nucleus of the mother's egg into a donor egg with healthy mitochondria. Recent clinical trials found the technique led to normal pregnancies and embryo development without increasing health risks. While not risk-free, the technique could help reduce the risk of transmitting mitochondrial diseases, which currently affects about 1 in 200 babies in the UK.
The procedure is called as "three-parent" in vitro fertilization because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a healthier female donor to prevent some serious incurable diseases passing on.
About us: FertilityConsultants.ca is people choice of consulting firm International Surrogacy in Canada which is fully devoted in helping couples who are having difficulty in trying to conceive.
Synthetic biology with Three parent Baby presentation and legal issues relate...Vikram Jeet Singh
This presentation deals with the use of synthetic biology in current world to produce synthetic microorganisms and issues related to that. Three parent baby is also a part of synthetic biology where faulty mitochondria of one mother are replaced by healthy mitochondria of other women. It is a revolution towards the production of the designer baby. This designer baby will be a concern shortly as human are acting like God and may be started to produce the baby with other unknown defects or diseases which might be uncurable in the near future.
The procedure is called as "three-parent" in vitro fertilization because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a healthier female donor to prevent some serious incurable diseases passing on.
About us: FertilityConsultants.ca is people choice of consulting firm International Surrogacy in Canada which is fully devoted in helping couples who are having difficulty in trying to conceive.
Synthetic biology with Three parent Baby presentation and legal issues relate...Vikram Jeet Singh
This presentation deals with the use of synthetic biology in current world to produce synthetic microorganisms and issues related to that. Three parent baby is also a part of synthetic biology where faulty mitochondria of one mother are replaced by healthy mitochondria of other women. It is a revolution towards the production of the designer baby. This designer baby will be a concern shortly as human are acting like God and may be started to produce the baby with other unknown defects or diseases which might be uncurable in the near future.
In vitro Fertilization- IVF is a form of assisted reproductive technology (ART).In this special medical techniques are used to help a woman become pregnant. IVF, coupled with embryo transfer, in humans is aimed to enable couples suffering from certain types of sterility to have children.
Babies developed from this approach are known as "test-tube babies."
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
Dr. Philippe Grandjean on Chemical Brain DrainDES Daughter
How the Next Generation's Brain Functions are Endangered by EDCs and Other Environmental Chemicals
by the Collaborative on Health and the Environment
Dr. Philippe Grandjean suggests that new scientific insights reveal that the next generation's brain functions are endangered by environmental chemicals. The fetus is not protected by the placenta and therefore shares the mother's cumulated exposures to toxic chemicals. Infants and children are likewise exposed to a cocktail of foreign substances against which the body has no innate defense. Prenatal and early postnatal brain development is an extremely complex process that we now know is uniquely vulnerable. Lead, mercury and a few other substances have long been known to be toxic to brain development. Recent research suggests that many chemicals, perhaps thousands, may cause similar effects because they can gain access to the developing brain and exert their toxicity to brain cells. This new insight needs to be translated into public policy to protect the brain functions of the next generation. On this call Dr. Grandjean discussed what he terms "chemical brain drain" and how we might work to protect the brain health of future generations.
Sources: http://www.healthandenvironment.org/partnership_calls/14316?res
In vitro Fertilization- IVF is a form of assisted reproductive technology (ART).In this special medical techniques are used to help a woman become pregnant. IVF, coupled with embryo transfer, in humans is aimed to enable couples suffering from certain types of sterility to have children.
Babies developed from this approach are known as "test-tube babies."
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
Dr. Philippe Grandjean on Chemical Brain DrainDES Daughter
How the Next Generation's Brain Functions are Endangered by EDCs and Other Environmental Chemicals
by the Collaborative on Health and the Environment
Dr. Philippe Grandjean suggests that new scientific insights reveal that the next generation's brain functions are endangered by environmental chemicals. The fetus is not protected by the placenta and therefore shares the mother's cumulated exposures to toxic chemicals. Infants and children are likewise exposed to a cocktail of foreign substances against which the body has no innate defense. Prenatal and early postnatal brain development is an extremely complex process that we now know is uniquely vulnerable. Lead, mercury and a few other substances have long been known to be toxic to brain development. Recent research suggests that many chemicals, perhaps thousands, may cause similar effects because they can gain access to the developing brain and exert their toxicity to brain cells. This new insight needs to be translated into public policy to protect the brain functions of the next generation. On this call Dr. Grandjean discussed what he terms "chemical brain drain" and how we might work to protect the brain health of future generations.
Sources: http://www.healthandenvironment.org/partnership_calls/14316?res
The industry is all about Chat bots, Speech synthesis and recognition, Natural Language Processing... In this session, we'll detail how to build advanced interactions in Javascript with Cisco Spark and Tropo. We'll take the example of the Interactive Voice Responder that was setup for the CodeMotion Milan Conference this year. Last part of the session will be interactive so that we can share our various experiences with frameworks and industry gaps.
Referring to the combination of vitamins and supplements used as therapies in the treatment and management of mitochondrial disease and mitochondrial dysfunction, the "Mito Cocktail" is unique to every patient.
cell cloning- Therapeutic and reproductive cloningAlisha Shaikh
Cloning is a process where genetically identical types of cells, tissues or organism is being produced. There are two types of cloning- Reproductive and therapeutic cloning.
Since the birth of Louise Brown, the first baby born through in vitro fertilization, in 1978, assisted reproductive technology has advanced significantly. The success rate of in vitro fertilization (IVF) has risen dramatically over the last four decades as a result of developments in incubation methods, micromanipulation technology, and a general understanding of assisted reproduction.
This presentation contains various details from history of cloning to what one should expect in the future from cloning and also different cloning methods
Cloning(human cloning) sreenivas.m final pptSreenivas vasu
cloning types in detail .... easy ppt for seminars....................................................................................................................................................................................
Human Genome Engineering, Recent discoveries, Types of Designer babies, Methods used for Designer Babies, CRISPR, ETHICAL CONSIDERATION OF HUMAN GENOME ENGINEERING
Similar to Three parent babies will be reality soon happy ho (20)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
2. About “Three-parent babies”
• “Three-parent babies” could soon become a reality
after a controversial fertility treatment against
mitochondrial disease proved safe and successful in
pre-clinical trials. The IVF-based technique, known as
“early pronuclear transfer” was created to help
mothers avoid passing on defective mitochondrial
DNA to their offspring.
3. Contd….
• In the UK, about one in 200 babies develop
mitochondrial disease. Mitochondria are organelles
responsible for creating the energy needed by the
cells to function. They are found in the body of every
living cells, separated from the nucleus which holds
the nuclear DNA – the genetic characteristics
inherited both from the mother and the father.
4. Contd….
• Within the mitochondria, specific mitochondrial DNA
is also found. It is necessary for normal
mitochondrial function, and is defective in children
who have the disease.
5. Contd….
• “Early pronuclear transfer” involves removing the
nucleus of a fertilised egg and transferring it into a
nucleus-free egg from a donor with healthy
mitochondria. The embryo thus inherits the genetic
characteristics of both his parents, while avoiding the
mother’s defective mitochondria.
6. Contd….
• While the method has raised a number of ethical
concerns, the latest study published in the journal
Nature, suggests there should be no worries about
its technical feasibility nor about the risks for
embryos’ safety.
7. Contd….
• Scientists from the Wellcome Trust Centre
for Mitochondrial Disease at Newcastle
University tested the technique, using 500
eggs from 64 donor women. They found that
it led to normal pregnancies and embryo
development, whilst also reducing the risk of
babies having mitochondrial disease.
8. Contd….
• To reach this conclusion, the scientists
analysed thousands of genes in embryo
single cells. They compared them to
embryos born from traditional IVF, detecting
no difference between the two types of
embryos.
• Embryos created through the “early
pronuclear transfer” were also no more
likely to suffer from genetic anomalies, birth
defects, or miscarriage.
9. Contd….
• Three-parent IVF could prevent mothers
passing potentially fatal mitochondrial
diseases to their childrenDoH
Mitochondrial disease risk is reduced
11. Contd….
• The risk of transmitting mitochondrial DNA
was also greatly reduced, though not
completely, as research on stem cells
derived from the embryos has revealed. In
some cases, defective mitochondrial DNA
still ended up in the embryo, because
residues from the fertilised egg stuck to the
nucleus when it was extracted.
12. Contd….
• The bottom line is that the risk of
transmitting mitochondrial disease through
this technique does exist, but it is much
lower than if people decide to conceive
naturally.
• For families who have been affected by the
disease, it would be a step forward.